These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18240906)

  • 1. Application of metabonomics in drug development.
    Keun HC; Athersuch TJ
    Pharmacogenomics; 2007 Jul; 8(7):731-41. PubMed ID: 18240906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabonomic modeling of drug toxicity.
    Keun HC
    Pharmacol Ther; 2006 Jan; 109(1-2):92-106. PubMed ID: 16051371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabonomics: systems biology in pharmaceutical research and development.
    Lindon JC; Holmes E; Nicholson JK
    Curr Opin Mol Ther; 2004 Jun; 6(3):265-72. PubMed ID: 15264428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profiling as a tool for understanding mechanisms of toxicity.
    Clarke CJ; Haselden JN
    Toxicol Pathol; 2008 Jan; 36(1):140-7. PubMed ID: 18337232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabonomics in pharmaceutical discovery and development.
    Robertson DG; Reily MD; Baker JD
    J Proteome Res; 2007 Feb; 6(2):526-39. PubMed ID: 17269709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.
    Lindon JC; Holmes E; Bollard ME; Stanley EG; Nicholson JK
    Biomarkers; 2004; 9(1):1-31. PubMed ID: 15204308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in metabonomics].
    Xu GW; Lu X; Yang SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):701-11. PubMed ID: 18595244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.
    Nicholson JK; Everett JR; Lindon JC
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):135-9. PubMed ID: 22248264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method].
    Naraoka H; Suzumura K; Takeuchi K; Sasayama T
    Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration.
    Griffin JL; Bollard ME
    Curr Drug Metab; 2004 Oct; 5(5):389-98. PubMed ID: 15544433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites in safety testing: metabolite identification strategies in discovery and development.
    Nedderman AN
    Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabonomics techniques and applications to pharmaceutical research & development.
    Lindon JC; Holmes E; Nicholson JK
    Pharm Res; 2006 Jun; 23(6):1075-88. PubMed ID: 16715371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics and biochemical profiling in drug discovery and development.
    Watkins SM; German JB
    Curr Opin Mol Ther; 2002 Jun; 4(3):224-8. PubMed ID: 12139307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery for drug development and translational medicine using metabonomics.
    Keun HC
    Ernst Schering Found Symp Proc; 2007; (4):79-98. PubMed ID: 18811054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomics in toxicology: a review.
    Robertson DG
    Toxicol Sci; 2005 Jun; 85(2):809-22. PubMed ID: 15689416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of metabonomics at the interface between drug metabolism and safety assessment.
    Waters NJ
    Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabonomics: a useful tool for the future surgeon.
    Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
    J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
    Serkova NJ; Niemann CU
    Expert Rev Mol Diagn; 2006 Sep; 6(5):717-31. PubMed ID: 17009906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.